Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-07-31	$0.2500	-.--%	8,600
26-07-30	$0.2500	-3.85%	7,003
26-07-29	$0.2600	-1.89%	8,956
26-07-28	$0.2650	-.--%	2,700
26-07-27	$0.2650	+6.00%	4,500

Delayed Quote Canadian Securities Exchange

More quotes

Income Statement and Estimates

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Canadian Securities Exchange Other stock markets 09:30:06 2026-07-31 EDT			5-day change	1st Jan Change
0.2500 ^CAD	-.--%		-.--%	-10.71%

07-02	Izotropic Corporation and Izotropic Africa Executes Formal Agreement for Exclusive Commercialization and Distribution of IzoView in Africa and Gulf Cooperation Council	CI
04-29	Izotropic Corporation Launches Izotropic Africa Operations in Casablanca	CI

Market Cap	12.43M 10.8M 10.05M 9.23M 17.43M 1.19B 17.7M 119M 46.51M 591M 46.66M 45.64M 1.98B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	12.43M 10.8M 10.05M 9.23M 17.43M 1.19B 17.7M 119M 46.51M 591M 46.66M 45.64M 1.98B	EV / Sales 2026 *	2.49x	EV / Sales 2027 *	1.24x
Free-Float	91.99%	Yield 2026 *	-	Yield 2027 *	-

07-02	Izotropic Corporation and Izotropic Africa Executes Formal Agreement for Exclusive Commercialization and Distribution of IzoView in Africa and Gulf Cooperation Council	CI
04-29	Izotropic Corporation Launches Izotropic Africa Operations in Casablanca	CI
03-27	Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026	CI
02-18	Izotropic Corporation And Business Group Enter Letter Agreement To Establish Izotropic Africa For Licensing, Marketing, Distribution, And Manufacturing Of IzoView Breast CT In Africa And GCC	CI
02-04	Izotropic Raises $300,000 Via a Non-Brokered Private Placement and Announces Debt Settlement	MT
02-03	Izotropic Corporation announced that it has received CAD 0.3 million in funding	CI
01-28	Izotropic to Raise $300,000 Via Non-Brokered Private Placement	MT
01-27	Izotropic Corporation announced that it expects to receive CAD 0.3 million in funding	CI
12-30	Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025	CI
25-10-23	Izotropic Corporation Develops the IzoView Breast CT Imaging System	CI
25-09-29	Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2025	CI
25-09-23	Izotropic Launches Personalized Radiation Dose Feature For Breast CT Scans	MT
25-09-23	Izotropic's IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose	CI

07-02	Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC	NE
04-29	Izotropic Africa Launches Operations in Casablanca	NE
04-21	Izotropic Announces Debt Settlement	NE
02-25	Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health	NE
02-18	Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC	NE

Izotropic Corporation Stock

Stocks

IZO

CA46604F1099

Advanced Medical Equipment & Technology

Valuation: Izotropic Corporation

Chart: Izotropic Corporation

Latest news : Izotropic Corporation

Press Releases: Izotropic Corporation

News in other languages: Izotropic Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Izotropic Corporation

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise

25-05-20	FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
25-05-20	FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
24-01-31	Izotropic erhält Antwort von der US-Behörde FDA
24-01-31	Izotropic erhält Antwort von der US-Behörde FDA
24-01-10	Izotropic gibt Updates zu regulatorischen und betrieblichen Themen

1 week	0.24	0.27
1 month	0.23	0.3
Current year	0.19	0.33
1 year	0.19	0.49
3 years	0.04	0.49
5 years	0.04	1.24
10 years	0.04	1.56

Manager	Title	Age	Since
Robert Louis Thast CEO	Chief Executive Officer	73	2023-05-31
Ralph Proceviat DFI	Director of Finance/CFO	75	2022-12-31
Younes Achkire COO	Chief Operating Officer	-	2022-12-31

Director	Title	Age	Since
Robert Louis Thast BRD	Director/Board Member	73	2016-05-18
Ali Sodagar BRD	Director/Board Member	51	2017-05-21
John Boone BRD	Director/Board Member	71	2017-04-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/18/25	Ralph Proceviat	Option	Chief Financial Officer	100,000	0.1761%
9/18/25	Ralph Proceviat	Option	Chief Financial Officer	100,000	0.1761%
9/17/25	Ralph Proceviat	Sell	Chief Financial Officer	100,000	0.1761%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IZOTROPIC CORPORATION	-.--%	-.--%	-5.66%	-3.85%	12.43M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-0.84%	+5.24%	-13.34%	-18.64%	14.02B
IRAY GROUP	+4.81%	-6.82%	+37.66%	-8.13%	3.9B
SONOSCAPE MEDICAL CORP.	+1.81%	+11.70%	-36.87%	-55.63%	1.27B
IRADIMED CORPORATION	-4.57%	-3.84%	+55.74%	+106.83%	1.16B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.98%	+9.99%	-35.09%	-44.14%	1.18B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+1.35%	+5.63%	-43.85%	-	952M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+17.03%	+10.93%	+29.36%	+96.15%	500M
CAPSOVISION, INC.	-1.79%	+1.39%	+70.25%	-	329M
FISCHER MEDICAL VENTURES LIMITED	+0.36%	+2.02%	-59.87%	+221.90%	265M
Average	+2.01%	+1.28%	-0.17%	+36.81%	2.36B
Weighted average by Cap.	+0.66%	+2.16%	-3.55%	-8.30%

	2026 *	2027 *
Net sales	5M 4.35M 4.05M 3.71M 7.01M 477M 7.12M 47.69M 18.72M 238M 18.78M 18.37M 797M	10M 8.69M 8.09M 7.43M 14.03M 955M 14.25M 95.38M 37.43M 475M 37.56M 36.73M 1.59B
Net income	2.69M 2.34M 2.18M 2M 3.78M 257M 3.84M 25.69M 10.08M 128M 10.12M 9.9M 429M	6.63M 5.76M 5.36M 4.92M 9.3M 633M 9.44M 63.22M 24.81M 315M 24.9M 24.35M 1.06B
Net Debt	-	-